Supplementary Table 1 from BCMab1, A Monoclonal Antibody against Aberrantly Glycosylated Integrin α3β1, Has Potent Antitumor Activity of Bladder Cancer <i>In Vivo</i>
crossref(2023)
摘要
FACS and immunohistochemistry analysis of BCMab1 immunoreactivity to human cell lines and normal human tissues.
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要